Huang, C., Chen, J., Chen, C., Liu, G., Zhang, Y., Messing, E., . . . Chang, C. (2019). ASC-J9® increases the bladder cancer chemotherapy efficacy via altering the androgen receptor (AR) and NF-κB survival signals. J Exp Clin Cancer Res.

Huang, Chi-Ping, Jinbo Chen, Chi-Cheng Chen, Guodong Liu, Yong Zhang, Edward Messing, Shuyuan Yeh, και Chawnshang Chang. "ASC-J9® Increases the Bladder Cancer Chemotherapy Efficacy Via Altering the Androgen Receptor (AR) and NF-κB Survival Signals." J Exp Clin Cancer Res 2019.

Huang, Chi-Ping, et al. "ASC-J9® Increases the Bladder Cancer Chemotherapy Efficacy Via Altering the Androgen Receptor (AR) and NF-κB Survival Signals." J Exp Clin Cancer Res 2019.